To this aim, we mined breast cancer RNA-Seq data publicly available in The Cancer Genome Atlas (TCGA) [25], and stratified all samples in two groups: one with low ERβ mRNA expression level (below first quartile), and the other with high ERβ mRNA expression (above third quartile). Here, ESR2 is linked to breast cancer.